Lymph node management in patients with paratesticular rhabdomyosarcoma: A Population-Based Analysis

Cancer

Volumn 119, Issue 17, 2013, Pages 3228-3233

  Dang, Nguyen D ^a   Dang, Phuong Thanh ^b   Samuelian, Jason ^a   Paulino, Arnold C ^a,c  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

lymph node dissection; paratesticular rhabdomyosarcoma; pediatric cancer; soft tissue sarcoma

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INFANT; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; OVERALL SURVIVAL; PARATESTICULAR RHABDOMYOSARCOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME;

LYMPH NODE DISSECTION; PARATESTICULAR RHABDOMYOSARCOMA; PEDIATRIC CANCER; SOFT-TISSUE SARCOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CONFOUNDING FACTORS (EPIDEMIOLOGY); HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RETROPERITONEAL SPACE; RETROSPECTIVE STUDIES; RHABDOMYOSARCOMA; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS;

EID: 84882693035     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28198     Document Type: Article

References (11)

1. Skoog SJ,. Benign and malignant pediatric scrotal masses. Pediatr Clin North Am. 1997; 44: 1229-1250.
2. Moroni M, Nesi G, Travaglini F, Rizzo M, Amorosi A, Dominici A,. Rhabdomyosarcoma of the spermatic cord. A case report with review of the literature. Urol Int. 2003; 71: 114-117.
3. Raney RB Jr, Tefft M, Lawrence W Jr, et al. Paratesticular sarcoma in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Studies I and II, 1973-1983. Cancer. 1987; 60: 2337-2343.
4. National Cancer Institute. Phase III Study of Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiotherapy in Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma. Children's Oncology Group ARST0331 Protocol. cancer.gov/clinicaltrials/search/view?cdrid=347078&version= healthprofessional. Accessed May 20, 2013.
5. Wiener ES, Anderson JR, Ojimba JI, et al. Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Semin Pediatr Surg. 2001; 10: 146-152.
6. Ferrari A, Bisogno G, Casanova M, et al. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group. J Clin Oncol. 2002; 20: 449-455.
7. Stewart RJ, Martelli H, Oberlin O, et al. International Society of Pediatric Oncology. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology. J Clin Oncol. 2003; 21: 793-798.
8. Heyn R, Raney RB Jr, Hays DM, et al. Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol. 1992; 10: 614-623.
9. Tomaszewski JJ, Sweeney DD, Kavoussi LR, Ost MC,. Laparoscopic retroperitoneal lymph node dissection for high-risk pediatric patients with paratesticular rhabdomyosarcoma. J Endourol. 2010; 24: 31-34.
10. Skolarus TA, Bhayani SB, Chiang HC, et al. Laparoscopic retroperitoneal lymph node dissection for low-stage testicular cancer. J Endourol. 2008; 22: 1485-1489.
11. Federico SM, Spunt SL, Krasin MJ, et al. Comparison of PET-CT and conventional imaging in staging pediatric rhabdomyosarcoma [published online ahead of print December 19, 2012 ]. Pediatr Blood Cancer. doi: 10.1002/pbc.24430.